BSECompany Update7 Aug 2026 · 7 Aug 2026, 10:15 am

Board of Directors of Aequs Limited have approved Aequs Restricted Stock Unit Plan 2026 and Amendment to the Aequs Employee Stock Option Plan 2025.

Aequs Ltd · 544634

✦ AI SummaryMgmt Change

Aequs Ltd has approved the adoption of Aequs Restricted Stock Unit Plan 2026 and amendment to the Aequs Employee Stock Option Plan 2025, and granted 2,70,000 Employee Stock Options under ESOP 2025 to eligible employees.

Analysis Scores

Earnings Impact2/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Aequs Ltd - 544634 - Approval Of Aequs Restricted Stock Unit Plan 2026 And Amendment To The Aequs Employee Stock Option Plan 2025

Attachments (1)

📄

90f054ad-9add-4c22-9123-3e166d061fbe.pdf

pdf

Download →
View document text
August 07, 2026 National Stock Exchange of India Limited, BSE Limited, Exchange Plaza, C-1, Block G, 20th Floor, P.J. Towers, Bandra Kurla Complex, Bandra (E), Dalal Street, Mumbai – 400 051 Mumbai – 400 001 NSE Scrip Symbol: AEQUS BSE Scrip Code: 544634 Subject: Intimation under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir / Madam, Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”), we wish to inform you that the Board of Directors of the Company at their meeting held today, i.e., Friday, August 07, 2026 which commenced at 09:15 AM (IST) and concluded at 09:45 AM (IST) inter-alia, based on the recommendation of the Nomination and Remuneration Committee, have considered and approved the following, subject to applicable provisions of the Companies Act, 2013 and the Listing Regulations, including amendments, if any: a. Adoption of Aequs Restricted Stock Unit Plan 2026 (“RSU 2026”) The Board approved the adoption of the RSU 2026 for eligible employees of the Company, its subsidiary companies and associate companies (including joint venture companies), whether existing or future, in India or outside India, by utilising 1,500,000 ungranted stock options earmarked from the existing Aequs Employee Stock Option Plan 2025 pool, in accordance with the applicable provisions of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021, subject to the approval of the shareholders of the Company at the ensuing Annual General Meeting. b. Amendment of Aequs Employee Stock Option Plan 2025 (“ESOP 2025”) The Board approved the amendment to ESOP 2025 to, inter alia, (i) extend the benefits of the Plan to eligible employees of the Company, its associate companies (including joint venture companies), whether existing or future, in India or outside India; and (ii) earmark 1,500,000 ungranted stock options from the existing ESOP 2025 pool for implementation of the Aequs Restricted Stock Unit Plan 2026 ("RSU 2026"), resulting in a corresponding reduction in the ungranted options available for future grants under ESOP 2025, in accordance with the applicable provisions of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021, subject to the approval of the shareholders of the Company at the ensuing Annual General Meeting. Further, the Board of directors approved the notice of 26th Annual General Meeting of the shareholders, scheduled to be held on Friday, September 04, 2026 at 4:00 PM (IST) through Video Conferencing ("VC") / Other Audio Visual Means ("OAVM"), to transact the business as set out in the Notice of the AGM. The detailed notice convening the AGM will be issued separately in due course of time. Aequs Limited (formerly known as Aequs Private Limited) Corporate Identity Number: L80302KA2000PLC026760 Registered Office: Aequs Tower, No. 55, Whitefield Main Road, Mahadevapura Post, Bengaluru - 560048, Karnataka, India T: + 91 080 61348000 Corporate Office: Aequs SEZ, No. 437/A, Hattargi Village, Hukkeri Taluk, Belagavi – 591243, Karnataka, India T: +91 0831 4222500 Website: www.aequs.com Email: investor.relations@aequs.com Also, we would like to inform you that the Nomination and Remuneration Committee (“NRC”) of the Board of Directors of the Company has approved the grant of 2,70,000 Employee Stock Options (ESOPs) under Aequs Employee Stock Option Plan 2025 (“ESOP 2025”) to the eligible employee(s) under Aequs Employee Stock Option Plan 2025 on August 07, 2026. The details as required under Regulation 30 read with Schedule Ill of the Listing Regulations, 2015 and SEBI Circular No. HO/CFD/PoD2/I/3762/2026 dated January 30, 2026, as Annexure 1. The above announcement will also be made available on the website of the Company and can be accessed using the link i.e. https://www.aequs.com/investor/ Thanking You, For Aequs Limited Ravi Mallikarjun Hugar Company Secretary and Compliance Officer Membership Number: A20823 Encl.: as above Aequs Limited (formerly known as Aequs Private Limited) Corporate Identity Number: L80302KA2000PLC026760 Registered Office: Aequs Tower, No. 55, Whitefield Main Road, Mahadevapura Post, Bengaluru - 560048, Karnataka, India T: + 91 080 61348000 Corporate Office: Aequs SEZ, No. 437/A, Hattargi Village, Hukkeri Taluk, Belagavi – 591243, Karnataka, India T: +91 0831 4222500 Website: www.aequs.com Email: investor.relations@aequs.com ANNEXURE 1 Sr. No. Particulars Details 1 Brief details of options granted 2,70,000 Options granted pursuant to Aequs Employee Stock Option Plan 2025 (“ESOP 2025”) to the eligible employee(s) of the Company. 2 Whether the scheme is in terms of Yes SEBI (SBEB) Regulations, 2021 (if applicable); 3 Total number of shares covered by 2,70,000 shares of Rs. 10/- each these options 4 Pricing formula Exercise Price is Rs. 239.50 per option. 5 Options vested Not Applicable, as this disclosure is pertaining to grant of Stock Options under the ESOP 2025 6 Time within which options may be Subject to fulfilment of vesting conditions as per ESOP 2025, exercised. options shall be exercised within three (3) years from the date of respective vesting. 7 Options exercised Not Applicable, as this disclosure is pertaining to grant of Options under the ESOP 2025. 8 Money realized by exercise of Not Applicable, as this disclosure is pertaining to grant of options Options under the ESOP 2025. 9 The total number of shares arising as 2,70,000 Equity Shares of face value of Rs. 10/‐ each will arise a result of exercise of option deeming all granted options are vested and exercised. 10 Options lapsed Not Applicable, as this disclosure is pertaining to grant of Options under the ESOP 2025. 11 Variation of terms of options Not applicable 12 Brief details of significant terms Stock Options granted shall have a Vesting period of minimum 1 (One) Year from the date of Grant and all Stock Options granted shall Vest as per the Vesting schedule specified in the grant letter. The grant of Stock Options is based upon the eligibility criteria as mentioned in ESOP 2025. The Stock Options granted, once vested shall entitle the Stock Option holder to acquire equal number of Equity Shares, upon payment of exercise price and applicable taxes in accordance with terms and conditions of the ESOP 2025. 13 Subsequent changes or cancellation Not Applicable, as this disclosure is pertaining to grant of or exercise of such options Options under the ESOP 2025. 14 Diluted earnings per share pursuant Not Applicable, as this disclosure is pertaining to grant of to issue of equity shares on exercise Options under the ESOP 2025. of options Aequs Limited (formerly known as Aequs Private Limited) Corporate Identity Number: L80302KA2000PLC026760 Registered Office: Aequs Tower, No. 55, Whitefield Main Road, Mahadevapura Post, Bengaluru - 560048, Karnataka, India T: + 91 080 61348000 Corporate Office: Aequs SEZ, No. 437/A, Hattargi Village, Hukkeri Taluk, Belagavi – 591243, Karnataka, India T: +91 0831 4222500 Website: www.aequs.com Email: investor.relations@aequs.com